ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Grassley Seeks Data On Sponsored Travel By NCI Scientists

October 29, 2010

DCE Advisors Okay Contract Recompetitions For Epidemiology

November 18, 1994

Six Surgical Oncology Grants To Be Funded

June 8, 1984

Colorectal Cancer Gene Carriers Seek Screening More Frequently, Study Finds

November 29, 2002

Policy Of 5,000 Grants Meant As Floor, Not Ceiling, Former White House Advisor Insists

March 8, 1985

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990